Takuya Kitamoto

8.3k total citations · 1 hit paper
56 papers, 2.7k citations indexed

About

Takuya Kitamoto is a scholar working on Molecular Biology, Toxicology and Epidemiology. According to data from OpenAlex, Takuya Kitamoto has authored 56 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 13 papers in Toxicology and 10 papers in Epidemiology. Recurrent topics in Takuya Kitamoto's work include Forensic Toxicology and Drug Analysis (13 papers), Retinoids in leukemia and cellular processes (7 papers) and Liver Disease Diagnosis and Treatment (7 papers). Takuya Kitamoto is often cited by papers focused on Forensic Toxicology and Drug Analysis (13 papers), Retinoids in leukemia and cellular processes (7 papers) and Liver Disease Diagnosis and Treatment (7 papers). Takuya Kitamoto collaborates with scholars based in Japan, France and Norway. Takuya Kitamoto's co-authors include Yoshikazu Masuhiro, Shigeaki Kato, Daniel Metzger, Shoichi Masushige, Hiroyuki Kawashima, Eisuke Nishida, Hideki Endoh, Haruna Sasaki, Yukiko Gotoh and Pierre Chambon and has published in prestigious journals such as Science, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

Takuya Kitamoto

45 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Activation of the Estrogen Receptor Through Phosphorylation by Mitogen-Activated Protein Kinase

1995 1.6k citations Shigeaki Kato, Yoshikazu Masuhiro et al. profile →

Peers

Countries citing papers authored by Takuya Kitamoto

Since Specialization

Citations

This map shows the geographic impact of Takuya Kitamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takuya Kitamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takuya Kitamoto more than expected).

Fields of papers citing papers by Takuya Kitamoto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takuya Kitamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takuya Kitamoto. The network helps show where Takuya Kitamoto may publish in the future.

Co-authorship network of co-authors of Takuya Kitamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Takuya Kitamoto. A scholar is included among the top collaborators of Takuya Kitamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takuya Kitamoto. Takuya Kitamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Changes in the plasma protein‐binding rate of remifentanil during cardiopulmonary bypass 2024 ·British Journal of Clinical Pharmacology ·(unknown), Tadayoshi Kurita, (unknown), Takuya Kitamoto, Masako Suzuki, Yoshiki Nakajima	0
2	Detection of new metabolites of risperidone in the solid tissues and body fluids obtained from two cadavers by high resolution tandem mass spectrometry 2024 ·Forensic Science International ·Kayoko Minakata, Hideki Nozawa, Itaru Yamagishi, (unknown), Masako Suzuki, Takuya Kitamoto, (unknown), Осаму Сузукі, Koutaro Hasegawa	1
3	Uric acid is a major chemical constituent for the whitish coloration in the medaka leucophores 2023 ·Pigment Cell & Melanoma Research ·Makoto Goda, (unknown), Takuya Kitamoto, (unknown), Hisashi Hashimoto	3
4	Lung adenocarcinoma and squamous cell carcinoma difficult for immunohistochemical diagnosis can be distinguished by lipid profile 2023 ·Scientific Reports ·(unknown), (unknown), (unknown), (unknown), (unknown), Akikazu Kawase, (unknown), Takuya Kitamoto, Minako Kondo, (unknown), Tao Hong, Yutaka Takahashi, Takumi Sakamoto, Tomoaki Kahyo, Haruhiko Sugimura, Mitsutoshi Setou, Norihiko Shiiya, Kazuhito Funai	6
5	Quantification of olanzapine and its three metabolites by liquid chromatography–tandem mass spectrometry in human body fluids obtained from four deceased, and confirmation of the reduction from olanzapine N-oxide to olanzapine in whole blood in vitro 2023 ·Forensic Toxicology ·Hideki Nozawa, Kayoko Minakata, Koutaro Hasegawa, Itaru Yamagishi, (unknown), Masako Suzuki, Takuya Kitamoto, (unknown), Kanako Watanabe, Осаму Сузукі	3
6	Lipid biomarkers that reflect postoperative recurrence risk in lung cancer patients who smoke: a case–control study 2023 ·Lipids in Health and Disease ·(unknown), Tomoaki Kahyo, (unknown), Keigo Sekihara, Akikazu Kawase, Minako Kondo, Takuya Kitamoto, Yutaka Takahashi, Tomohito Sato, Haruhiko Sugimura, Norihiko Shiiya, Mitsutoshi Setou, Kazuhito Funai	5
7	Quantification of risperidone and paliperidone by liquid chromatography–tandem mass spectrometry in biological fluids and solid tissues obtained from two deceased using the standard addition method 2023 ·Legal Medicine ·Hideki Nozawa, Kayoko Minakata, Koutaro Hasegawa, Itaru Yamagishi, (unknown), (unknown), Masako Suzuki, Takuya Kitamoto, (unknown), Осаму Сузукі	0
8	Updating “Data on changes in lipid profiles during the differentiation and maturation of human subcutaneous white adipocytes analyzed using chromatographic and bioinformatic tools” with data on the changes in protein profiles 2023 ·Data in Brief ·Takuya Kitamoto, Aya Kitamoto	1
9	Data on changes in lipid profiles during the differentiation and maturation of human subcutaneous white adipocytes analyzed using chromatographic and bioinformatic tools 2022 ·Data in Brief ·Aya Kitamoto, Takuya Kitamoto	2
10	A single oral supplementation of nicotinamide within the daily tolerable upper level increases blood NAD+ levels in healthy subjects 2021 ·SHILAP Revista de lepidopterología ·Tetsufumi Ito, Tomohito Sato, (unknown), (unknown), Takuya Kitamoto, Keiichi Odagiri, Mitsutoshi Setou	15
11	Sensitive quantification of BB-22 and its metabolite BB-22 3-carboxyindole, and characterization of new metabolites in authentic urine and/or serum specimens obtained from three individuals by LC–QTRAP-MS/MS and high-resolution LC–Orbitrap-MS/MS 2018 ·Forensic Toxicology ·Kayoko Minakata, Koutaro Hasegawa, Hideki Nozawa, Itaru Yamagishi, Takeji Saitoh, (unknown), Masako Suzuki, Takuya Kitamoto, Осаму Сузукі, Kanako Watanabe	15
12	Targeted-bisulfite sequence analysis of the methylation of CpG islands in genes encoding PNPLA3, SAMM50, and PARVB of patients with non-alcoholic fatty liver disease 2015 ·Journal of Hepatology ·Takuya Kitamoto, Aya Kitamoto, Yuji Ogawa, Yasushi Honda, Kento Imajo, Satoru Saito, Masato Yoneda, Takahiro Nakamura, Atsushi Nakajima, Kikuko Hotta	66
13	Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan 2013 ·Human Genetics ·Takuya Kitamoto, Aya Kitamoto, Masato Yoneda, Hideyuki Hyogo, Hidenori Ochi, Takahiro Nakamura, (unknown), Seiho Mizusawa, Takato Ueno, Kazuaki Chayama, Atsushi Nakajima, Kazuwa Nakao, Akihiro Sekine, Kikuko Hotta	152
14	On Computation of Approximate Eigenvalues and Eigenvectors 2002 ·IEICE Transactions on Fundamentals of Electronics Communications and Computer Sciences ·Takuya Kitamoto	0
15	p300 Mediates Functional Synergism between AF-1 and AF-2 of Estrogen Receptor α and β by Interacting Directly with the N-terminal A/B Domains 2000 ·Journal of Biological Chemistry ·Yôko Kobayashi, Takuya Kitamoto, Yoshikazu Masuhiro, Michiko Watanabe, (unknown), Daniel Metzger, Junn Yanagisawa, Shigeaki Kato	123
16	Efficient Computation of the Characteristic Polynomial of a Polynomial Matrix 1999 ·IEICE Transactions on Fundamentals of Electronics Communications and Computer Sciences ·Takuya Kitamoto	3
17	Increased 9,13-di-cis-retinoic acid in rat hepatic fibrosis: implication for a potential link between retinoid loss and TGF-β mediated fibrogenesis in vivo 1999 ·Journal of Hepatology ·Masataka Okuno, Takashi Sato, Takuya Kitamoto, Shoko Imai, Norifumi Kawada, Yasuhiro Suzuki, Hiroyuki Yoshimura, Hisataka Moriwaki, (unknown), Shoichi Masushige, Yasutoshi Muto, Scott L. Friedman, Shigeaki KATO, Soichi Kojima	64
18	ERC-55, a Binding Protein for the Papilloma Virus E6 Oncoprotein, Specifically Interacts with Vitamin D Receptor among Nuclear Receptors 1997 ·Biochemical and Biophysical Research Communications ·Takeshi Imai, Koichiro Matsuda, (unknown), (unknown), Yoshikazu Masuhiro, Takuya Kitamoto, Atsuko Ikenouchi, Kaori Suzuki, (unknown), (unknown), Yasuhisa Nogi, Masami Muramatsu, Hiroshi Handa, Shigeaki Kato	32
19	Intron Retention Generates a Novel Isoform of the Murine Vitamin D Receptor That Acts in a Dominant Negative Way on the Vitamin D Signaling Pathway 1996 ·Molecular and Cellular Biology ·Kanae Ebihara, Yoshikazu Masuhiro, Takuya Kitamoto, Miyuki Suzawa, Yoshikatsu Uematsu, Tatsuya Yoshizawa, Toshio Ono, Hideyuki Harada, Koichiro Matsuda, Tadao Hasegawa, Shoichi Masushige, Shigeaki Kato	75
20	Synthesis of 9E- and 9Z-Locked Retinoic Acid Analogs As Ligands for RAR and RXR. 1994 ·Chemical and Pharmaceutical Bulletin ·(unknown), Yasunori Aoyama, (unknown), Akimori Wada, Susumu Uchiyama, Takuya Kitamoto, Shoichi Masushige, Shigeaki Kato, Makoto Ito	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact